Spitalul Clinic Prof.Dr.Theodor Burghele

Clinical trials in this area focus on prostate cancer and bladder cancer, reflecting the site’s strong work in urologic oncology. These studies are designed to evaluate new treatment approaches, compare therapies, and better understand long-term outcomes for people with advanced or nonmuscle invasive disease.

• Studies in metastatic castration resistant prostate cancer and metastatic hormone-sensitive prostate cancer
• Research in nonmuscle invasive bladder cancer
• Trials assessing whether new therapies can improve disease control and survival

The Urology III department in Bucharest is contributing to research that may expand treatment options and support more effective cancer care.

This group of trials addresses cardiovascular disease, especially prevention of major events in adults with elevated risk factors. The research is aimed at testing whether new therapies can reduce the chance of serious heart-related complications and improve protection for patients with atherosclerotic cardiovascular disease and elevated Lp(a).

• Focus on atherosclerotic cardiovascular disease
• Studies involving elevated lipoprotein(a) as a key risk factor
• Evaluation of treatment effectiveness in preventing major cardiovascular events

These trials help clarify whether emerging therapies can lower long-term cardiovascular risk in people who remain vulnerable despite standard care.

The site is also involved in studies of female urogenital disorders, with a particular focus on stress urinary incontinence. This research explores whether new treatment options can reduce leakage episodes and improve daily comfort and quality of life for women affected by this condition.

• Trials in stress urinary incontinence
• Research involving women with obesity or overweight
• Testing therapies intended to improve symptom control and patient well-being

At this hospital, the work combines symptom-focused care with efforts to find better options for a common and often underreported condition.